News from acelrx pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 25, 2014, 21:59 ET
AcelRx Pharmaceuticals, Inc. (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Receives Complete Response Letter from FDA for New Drug Application for Zalviso™

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Jul 24, 2014, 23:49 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Jul 07, 2014, 03:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx and Grunenthal Announce Submission of European Marketing Authorization Application for ZALVISO™

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) and Grunenthal Group announced today that Grunenthal has submitted a Marketing Authorization...

Jun 19, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Present at the JMP Securities Healthcare Conference

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Jun 03, 2014, 07:00 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

Results of Cost Analysis Study Presented at ISPOR Meeting Identify Intravenous Patient-Controlled Analgesia (IV PCA) Costs of $200 to $240 for Two Days of Post-Surgical Pain Management

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Jun 02, 2014, 16:13 ET

AcelRx Pharmaceuticals Announces The Departure Of David Chung

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

May 29, 2014, 08:00 ET

AcelRx Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

AcelRx Pharmaceuticals to Present at the Jefferies Global Healthcare Conference /* Style Definitions...

May 19, 2014, 11:59 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference

AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference /* Style Definitions...

May 08, 2014, 16:05 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Reports First Quarter 2014 Financial Results

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

May 02, 2014, 07:30 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Thursday, May 8, 2014

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

May 01, 2014, 07:30 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Announces Zalviso™ and ARX-04 Data Presentations at the American Pain Society 33rd Annual Scientific Meeting

 AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Apr 04, 2014, 07:30 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Present at the 13th Annual Needham Healthcare Conference

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Mar 25, 2014, 07:30 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Appoints Timothy E. Morris as Chief Financial Officer

AcelRx Pharmaceuticals Appoints Timothy E. Morris as Chief Financial Officer /* Style Definitions...

Mar 07, 2014, 16:45 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Participate at the 26th Annual Roth Conference

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Mar 03, 2014, 16:05 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Feb 24, 2014, 07:30 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Hold Fourth Quarter and Annual 2013 Financial Results Conference Call and Webcast on Monday, March 3, 2014

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

Feb 05, 2014, 07:30 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals to Participate in Three Upcoming Investor Events

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Dec 19, 2013, 07:30 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Secures $40 Million Credit Facility with Hercules Technology Growth Capital

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Dec 16, 2013, 07:30 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx and Grunenthal Announce Collaboration for EU Commercialization of ZALVISO™

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) and Grunenthal GmbH announced today that they have entered into a commercial collaboration, covering...

Dec 13, 2013, 07:30 ET
AcelRx logo.  (PRNewsFoto/AcelRx Pharmaceuticals, Inc.)

AcelRx Pharmaceuticals Presents ARX-04 Dose-Finding Phase 2 Study Data at Anesthesia Medical Conference

 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge